Comparative Effect of Cinnamon, Glimepiride, and Their Combination on Glycated Hemoglobin in a High-Fat Diet/Alloxan-Induced Type 2 Diabetic Mouse Model
DOI:
https://doi.org/10.54361/ajmas.261140Keywords:
Cinnamon, Glimepiride, HbA1c, Type 2 Diabetes MellitusAbstract
Cinnamon has been reported to improve glycemic control, but its effect relative to standard sulfonylurea therapy is unclear. This study compared cinnamon, glimepiride, and their combination on glycated hemoglobin (HbA1c) in experimental type 2 diabetes mellitus (T2DM). T2DM was induced in mice by a high-fat diet for 2 weeks followed by a single dose of alloxan. Animals [n = 6 per group] were divided into five groups: control, untreated T2DM, cinnamon, glimepiride, and cinnamon plus glimepiride. Treatments were given for 4 weeks, after which HbA1c was measured. Data were checked for normality and homogeneity of variance and analyzed by one-way ANOVA with Tukey's post hoc test. HbA1c was markedly higher in the T2DM group (8.00 ± 0.14) than in controls (4.82 ± 0.72; p < 0.001). Cinnamon, glimepiride, and the combination significantly reduced HbA1c relative to untreated T2DM (6.10±0.37, 6.30±0.29, and 6.12±0.33, respectively; p < 0.001), although values remained above controls (p < 0.001). No significant differences were found among the three treated groups (Cinnamon vs glimepiride, p ≥ 0.85; cinnamon vs combination p ≥ 0.99; glimepiride vs combination p ≥0.9029). Cinnamon lowered HbA1c to a degree comparable to glimepiride, and the combination gave no significant additional benefit. Larger and longer studies are needed to confirm these findings.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Huda Gargoum, Nouh Aljarari, Nadeen Abdallah

This work is licensed under a Creative Commons Attribution 4.0 International License.











